Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

4.150

-0.210 (-4.82%)

At close: Feb 27, 2026, 4:00 PM EST

4.300

+0.150 (3.61%)

After-hours: Feb 27, 2026, 5:57 PM EST

Neuphoria Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	14.99	15.65	-	-	0.18	-
Other Revenue	-	-	-	-	3.99	0.7
Revenue	14.99	15.65	-	-	4.17	0.7
Revenue Growth (YoY)	2161.41%	-	-	-	499.60%	-66.32%
Cost of Revenue	-	-	-	-	11.02	4.32
Gross Profit	14.99	15.65	-	-	-6.85	-3.62
Selling, General & Admin	7.47	7.77	8.47	8.91	5.28	4.23
Research & Development	9.38	8.71	9.32	12.65	-	-
Other Operating Expenses	-	-	-	-	-0	-0.15
Operating Expenses	16.85	16.48	17.8	21.56	5.27	4.08
Operating Income	-1.86	-0.83	-17.8	-21.56	-12.12	-7.7
Interest Expense	-	-	-	-	-0.02	-1.07
Interest & Investment Income	0.41	0.17	0.22	0.32	0.01	0
Currency Exchange Gain (Loss)	-0.96	-0.41	-0.21	0.31	0.25	0.81
Other Non Operating Income (Expenses)	-2.67	-	-	-	-2.59	-1.22
EBT Excluding Unusual Items	-5.08	-1.08	-17.79	-20.93	-14.48	-9.18
Merger & Restructuring Charges	-1.24	-	-	-	-	-
Gain (Loss) on Sale of Investments	0.24	0.24	2.21	-0.59	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-0	-0.02
Other Unusual Items	-	-	-	-	-0.65	2.54
Pretax Income	-6.08	-0.84	-15.58	-21.52	-15.12	-6.66
Income Tax Expense	-0.42	-0.47	-0.09	-0.14	-0.13	-0.14
Earnings From Continuing Operations	-5.66	-0.37	-15.49	-21.38	-14.99	-6.52
Net Income	-5.66	-0.37	-15.49	-21.38	-14.99	-6.52
Net Income to Common	-5.66	-0.37	-15.49	-21.38	-14.99	-6.52
Shares Outstanding (Basic)	3	2	1	1,469	1,353	780
Shares Outstanding (Diluted)	3	2	1	1,469	1,353	780
Shares Change (YoY)	123.33%	95.01%	-99.94%	8.53%	73.52%	43.14%
EPS (Basic)	-2.18	-0.23	-18.62	-0.01	-0.01	-0.01
EPS (Diluted)	-2.18	-0.23	-18.62	-0.01	-0.01	-0.01
Free Cash Flow	-2.36	0.08	-14.68	-14.64	-14.99	-5.65
Free Cash Flow Per Share	-0.91	0.05	-17.64	-0.01	-0.01	-0.01
Gross Margin	100.00%	100.00%	-	-	-164.21%	-
Operating Margin	-12.43%	-5.30%	-	-	-290.62%	-1107.29%
Profit Margin	-37.79%	-2.36%	-	-	-359.34%	-937.11%
Free Cash Flow Margin	-15.76%	0.49%	-	-	-359.30%	-812.46%
EBITDA	-1.2	-0.17	-17.13	-20.9	-11.49	-7
EBITDA Margin	-8.01%	-1.06%	-	-	-275.36%	-
D&A For EBITDA	0.66	0.66	0.66	0.66	0.64	0.7
EBIT	-1.86	-0.83	-17.8	-21.56	-12.12	-7.7
EBIT Margin	-12.43%	-5.30%	-	-	-290.62%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q